Rho to Coordinate Study Sponsored by NIAID to Assess Systemic Allergic Reactions to Pfizer and Moderna COVID-19 Vaccines

Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced it is coordinating a study called Systemic Allergic Reactions to SARS-CoV-2 Vaccination to assess the proportion of participants with a systemic allergic reaction to the Pfizer-BioNTech and Moderna COVID-19 vaccines in populations at high risk for allergic reaction compared to a general population. This research will be important for further understanding potential risk factors for an allergic reaction to these particular vaccines, as well as to future vaccines that similarly use an mRNA nanoparticle platform. The study is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

Bruker Announces New Microbiology Products and Workflows for Microbial Identification and Infection Control at ECCMID 2021

QCI and IPQ Partner on Novel Approach to Drive More Effective Clinical Trials and Diagnostic Outcomes

Quantum Computing Inc. (QCI) (OTCQB: QUBT), the leader in bridging the power of classical and quantum computing, has announced a partnership with IPQ Analytics, LLC (IPQ), a life sciences and healthcare analytics innovator that provides a new breed of solutions for improved diagnostics and clinical trial outcomes. Through the partnership, IPQ will analyze real world data to generate novel temporally-defined disease models by combining its unique top-down knowledge graph representation of the patient journey with QCI’s quantum-powered community detection technology.

WCG Acquires Intrinsic Imaging, Leading Full-Service Medical Imaging Core Lab

Acquisition Enriches WCG’s Scientific and Regulatory Capabilities with Comprehensive Services Ensuring Quality and Validity of Clinical Trial Results Across Drug, Medical Device and Artificial Intelligence Studie

Idifarma launches accelerated pathway for complex drugs

Friday Health Plans Partners With HealthSparq to Power New Digital Experience for Members

Friday Health Plans implements HealthSparq's convenient and personalized provider search and price transparency tools for members.

Scitara Corporation unleashes universal connectivity to redefine lab of the future

Universal data connectivity for life science laboratories delivers seamless digital ecosystem and full automation of lab workflows – with the goal of accelerating scientific discovery

AUI and Accumen Partner to Increase Crisis Resilience to Natural and Manmade Disasters for Healthcare Sector

These new programs will ensure that healthcare organizations are better prepared to handle security threats, and power, water/waste management or supply chain disruptions.

LabVantage Solutions Introduces Secure Web Portal with Version 8.7 of Its LabVantage LIMS Platform

LabVantage 8.7 Introduces Secure Web Portal The latest version of LabVantage LIMS (laboratory information management system) includes a redesigned web portal that lets LabVantage customers extend appropriate access rights to their clients outside the laboratory. The new Portal protects customers’ valuable and sensitive data, while eliminating the need for manual requests for tests and other services. A new, next-generation user interface makes Portal features easier than ever to use for those outside the lab needing access to data but who are not familiar with LIMS. LabVantage 8.7 Highlights: • A secure customer self-service web Portal for external clients of the lab, ensuring faster and more complete client-submitted requests and direct access to more meaningful information and data. • Customers’ choice of “apps” that deliver various functions, such as Portal account management, request submissions, status tracking and test-results viewing, and requests for test kits. • Simple and intuitive user experience with clean, cockpit-style screens that allow users to navigate safely, efficiently, and with little or no training. • Lab administrator self-support leveraging existing LabVantage knowledge of functions, configuration tools, and other skills. • Available immediately.

BOC Sciences Offers Pseudouridine and Its Derivatives to Promote mRNA Development

Volpi partners with TOPIC Embedded Systems to offer intelligence-embedded optical measurement

Volpi, a world leader in optoelectronics with operations in the U.S. and Switzerland, has partnered with Netherlands-based TOPIC Embedded Systems, a leader in embedded intelligence, to expand its portfolio of optoelectronic measurement solutions and further advance its digital initiatives.

Alfa Chemistry Diversifies Supply of Active Pharmaceutical Ingredients for Pharmaceutical Preparation

Alfa Chemistry Materials Announces a New Product Offering of Quantum Dots

LIQUID STABLE, MATRIX PLUS™ CHEMISTRY REFERENCE MATERIALS NOW OFFERED BY VERICHEM LABORATORIES

Verichem’s MATRIX PLUS™ Chemistry Reference Kit is expressly intended to support overall system QC and CLIA compliance within the clinical laboratory.

FDS Amplicare Awards $25,000 Grant to CPESN Minnesota to Help 50 Community Pharmacies Expand Healthcare Services

FDS Amplicare Awards $25,000 Grant to CPESN Minnesota to Help 50 Community Pharmacies Expand Healthcare Services

Protheragen MedAI Fully Supports In Vitro Pharmacology Research for Drug Discovery

Flywheel and HealthMyne Partner to Provide End-to-End Radiomic Data Management and Analysis

Flywheel and HealthMyne: Combined technology solution to accelerate radiomics research and clinical trial outcomes

Standigm Secures Strategic Investment from SK Chemicals for Expanding its AI-Drug Development Capacity

Standigm Inc. (“Standigm”), a leading workflow artificial intelligence (AI) drug discovery company, and SK Chemicals Co., Ltd (“SK Chemicals”), a life science and green chemicals company, announced today that they have signed a strategic partnership contract for collaboration regarding clinical development of Standigm’s AI-driven drug candidate for non-alcoholic steatohepatitis (“NASH”) and the foundation of Standigm’s Synthesis Research Center within the headquarters of SK Chemicals. This partnership was made in conjunction with SK Chemicals’ participation in Standigm’s pre-IPO round of fundraising.

New Cotiviti Research Captures Healthcare Payer Shift from Postpay to Prepay Claim Integrity

Survey of >100 health plan leaders offers insight into the challenges of balancing prospective and retrospective approaches across enterprise payment integrity programs

VERICHEM LABORATORIES EXPANDS LINE OF BIO-SYNTHETIC CLINICAL REFERENCE MATERIALS FOR URINE CHEMISTRIES

VERICHEM now offers clinical laboratorians an extensive line of liquid stable and ready-to-use biosynthetic clinical reference materials for urine chemistry assays.